Effect of video-assisted patient education on compliance with therapy, quality of life, psychomorbidity, and cost of illness in irritable bowel syndrome

Research output: Contribution to journalArticle

Abstract

Objective: Patient education is important in irritable bowel syndrome (IBS), but its effects on outcomes have not been studied extensively. Methods: Patients were enrolled and prospectively divided into an interventional and usual care group. Both received standard of care, but the former additionally received video-assisted patient education. Self-administered questionnaires IBS-quality of life (QOL), Beck Anxiety-Depression Inventory II (BAI, BDI), and Hospital Anxiety and Depression Scale (HADS) were administered at baseline, 3 months, and 6 months. Compliance was defined as drug intake of >80% of the prescribed dose. COI included prospective, prevalence-based, societal perspective. Results: Of the 107 patients included, 84 [78.5%; male = 66 (78.57%); median age = 44 (range 20–77 years)] completed the follow up. While the median (inter-quartile range; IQR) QOL scores decreased significantly in both the groups (p < 0.001 for either group), the final scores were significantly better in the interventional group [49 (44–52.5) versus 80 (76–103), respectively; p < 0.005]. There was a significant improvement in the BDI; p < 0.001]. However, the rest did not achieve statistical significance. At 6 months, total median (IQR) semi-annual cost per patient was INR 14,639 (8253–17,909) [US $240 (135–294]. Conclusion: Video-assisted patient education should be a part of the treatment of IBS since it improves the QOL and depression scores.

Original languageEnglish
Pages (from-to)60-67
Number of pages8
JournalPostgraduate Medicine
Volume131
Issue number1
DOIs
Publication statusPublished - 02-01-2019

Fingerprint

Cost of Illness
Irritable Bowel Syndrome
Patient Education
Quality of Life
Depression
Anxiety
International Normalized Ratio
Standard of Care
Compliance
Therapeutics
Costs and Cost Analysis
Equipment and Supplies
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{8fa99fe5e3824de998ac3652344e2634,
title = "Effect of video-assisted patient education on compliance with therapy, quality of life, psychomorbidity, and cost of illness in irritable bowel syndrome",
abstract = "Objective: Patient education is important in irritable bowel syndrome (IBS), but its effects on outcomes have not been studied extensively. Methods: Patients were enrolled and prospectively divided into an interventional and usual care group. Both received standard of care, but the former additionally received video-assisted patient education. Self-administered questionnaires IBS-quality of life (QOL), Beck Anxiety-Depression Inventory II (BAI, BDI), and Hospital Anxiety and Depression Scale (HADS) were administered at baseline, 3 months, and 6 months. Compliance was defined as drug intake of >80{\%} of the prescribed dose. COI included prospective, prevalence-based, societal perspective. Results: Of the 107 patients included, 84 [78.5{\%}; male = 66 (78.57{\%}); median age = 44 (range 20–77 years)] completed the follow up. While the median (inter-quartile range; IQR) QOL scores decreased significantly in both the groups (p < 0.001 for either group), the final scores were significantly better in the interventional group [49 (44–52.5) versus 80 (76–103), respectively; p < 0.005]. There was a significant improvement in the BDI; p < 0.001]. However, the rest did not achieve statistical significance. At 6 months, total median (IQR) semi-annual cost per patient was INR 14,639 (8253–17,909) [US $240 (135–294]. Conclusion: Video-assisted patient education should be a part of the treatment of IBS since it improves the QOL and depression scores.",
author = "Nagesh Kamat and {Rajan Mallayasamy}, Surulivel and Sharma, {P. S.V.N.} and Asha Kamath and Ganesh Pai",
year = "2019",
month = "1",
day = "2",
doi = "10.1080/00325481.2019.1549458",
language = "English",
volume = "131",
pages = "60--67",
journal = "Postgraduate Medicine",
issn = "0032-5481",
publisher = "Medquest Communications LLC",
number = "1",

}

TY - JOUR

T1 - Effect of video-assisted patient education on compliance with therapy, quality of life, psychomorbidity, and cost of illness in irritable bowel syndrome

AU - Kamat, Nagesh

AU - Rajan Mallayasamy, Surulivel

AU - Sharma, P. S.V.N.

AU - Kamath, Asha

AU - Pai, Ganesh

PY - 2019/1/2

Y1 - 2019/1/2

N2 - Objective: Patient education is important in irritable bowel syndrome (IBS), but its effects on outcomes have not been studied extensively. Methods: Patients were enrolled and prospectively divided into an interventional and usual care group. Both received standard of care, but the former additionally received video-assisted patient education. Self-administered questionnaires IBS-quality of life (QOL), Beck Anxiety-Depression Inventory II (BAI, BDI), and Hospital Anxiety and Depression Scale (HADS) were administered at baseline, 3 months, and 6 months. Compliance was defined as drug intake of >80% of the prescribed dose. COI included prospective, prevalence-based, societal perspective. Results: Of the 107 patients included, 84 [78.5%; male = 66 (78.57%); median age = 44 (range 20–77 years)] completed the follow up. While the median (inter-quartile range; IQR) QOL scores decreased significantly in both the groups (p < 0.001 for either group), the final scores were significantly better in the interventional group [49 (44–52.5) versus 80 (76–103), respectively; p < 0.005]. There was a significant improvement in the BDI; p < 0.001]. However, the rest did not achieve statistical significance. At 6 months, total median (IQR) semi-annual cost per patient was INR 14,639 (8253–17,909) [US $240 (135–294]. Conclusion: Video-assisted patient education should be a part of the treatment of IBS since it improves the QOL and depression scores.

AB - Objective: Patient education is important in irritable bowel syndrome (IBS), but its effects on outcomes have not been studied extensively. Methods: Patients were enrolled and prospectively divided into an interventional and usual care group. Both received standard of care, but the former additionally received video-assisted patient education. Self-administered questionnaires IBS-quality of life (QOL), Beck Anxiety-Depression Inventory II (BAI, BDI), and Hospital Anxiety and Depression Scale (HADS) were administered at baseline, 3 months, and 6 months. Compliance was defined as drug intake of >80% of the prescribed dose. COI included prospective, prevalence-based, societal perspective. Results: Of the 107 patients included, 84 [78.5%; male = 66 (78.57%); median age = 44 (range 20–77 years)] completed the follow up. While the median (inter-quartile range; IQR) QOL scores decreased significantly in both the groups (p < 0.001 for either group), the final scores were significantly better in the interventional group [49 (44–52.5) versus 80 (76–103), respectively; p < 0.005]. There was a significant improvement in the BDI; p < 0.001]. However, the rest did not achieve statistical significance. At 6 months, total median (IQR) semi-annual cost per patient was INR 14,639 (8253–17,909) [US $240 (135–294]. Conclusion: Video-assisted patient education should be a part of the treatment of IBS since it improves the QOL and depression scores.

UR - http://www.scopus.com/inward/record.url?scp=85057339632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057339632&partnerID=8YFLogxK

U2 - 10.1080/00325481.2019.1549458

DO - 10.1080/00325481.2019.1549458

M3 - Article

C2 - 30445893

AN - SCOPUS:85057339632

VL - 131

SP - 60

EP - 67

JO - Postgraduate Medicine

JF - Postgraduate Medicine

SN - 0032-5481

IS - 1

ER -